Cure Pharma expands its DEA license to include authorization to manufacture both cannabis plant extracts and CBD within the scope of its patent portfolio.
Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says research claiming more than half of patients have problems swallowing traditional pills.
Following a busy few months, Capsugel spoke about the formation of its Dosage Form Solutions Unit, its technology and the integration of Encap at this year's Interphex in New York.
Aptar Pharma has launched a new twistable dry powder inhaler (DPI) which it says is a “cost effective” way to improve drug delivery as well as patient compliance.
Patheon is teaming up with formulation development services firm
Senopsys to offer pharma companies combined services to test and
improve drug flavour.
An Italian firm specialising in novel drug delivery technologies is
due to receive a lump sum of €1m following the successful
development of a new formulation of a GlaxoSmithKline (GSK) drug.
Pharmaceutical company Novartis has started building a pilot plant
at its Stein site near Basel in Switzerland to supply sterile
dosage forms for clinical trials.
3M has teamed up with MicroDose Technologies to market a new
metered dose inhaler that should be cheap to produce and deliver a
broad range of compounds.
UK-based BioProgress has elected to sell the rights to one of its
NROBE non-gelatine film technologies to FMC BioPolymer after
deciding that the program would benefit from being in the hands of
a bigger partner.